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Abstract—In contrast to peptide-based imidazolidin-4-ones, those synthesized from N-(a-aminoacyl) derivatives of the antimalarial drug,
primaquine and ketones are unexpectedly stable in pH 7.4 at 37 C. The kinetics of hydrolysis of primaquine-based imidazolidin-4-ones
were investigated in the pH range 0.3–13.5 at 60 C. The hydrolysis to the parent a-aminoacylprimaquine is characterized by sigmoidal-
shaped pH–rate profiles, reflecting the spontaneous decomposition of both unionized and protonated (at N-1) forms of the imidazolidin-4-
one. The kinetically determined pKa values are ca. 3.6–4.0, i.e., 4 pKa units lower than those of amino acid amides, thus implying that
hydrolysis of imidazolidin-4-ones at pH 7.4 involves the unionized form. Reactivity of this form decreases with the steric crowding of the
amino acid a-substituent. In contrast, the rate constant for the spontaneous decomposition of the unionized form increases sharply for
imidazolidin-4-ones derived from cyclic ketones, an observation that can be explained by the I-strain (internal strain) effect. These results
are consistent with a mechanism of hydrolysis involving an SN1-type unimolecular cleavage of the imidazolidin-4-one C2–N3 bond with
departure of an amide-leaving group. The mechanism for the decomposition of the protonated imidazolidin-4-one is likely to involve an
amide-carbonyl oxygen protonated species, followed by the C2–N3 bond scission, as supported by computational studies. The results herein
presented suggest that imidazolidin-4-ones derived from simple N-alkyl a-aminoamides are too stable and therefore, may be useful as slow
drug release prodrugs.
 2006 Elsevier Ltd. All rights reserved.1. Introduction
Compounds containing an a-aminoamide moiety, such as
peptides with a free N-terminal amino group, react with al-
dehydes and ketones to yield imidazolidin-4-ones, 1, as de-
picted in Scheme 1.1–4 In aqueous solutions, compounds 1
revert back to the parent a-aminoamide (peptide) and alde-
hyde or ketone at a rate that is dependent on pH, on the struc-
ture of the a-aminoamide substituents (R1 and R4), and on
the structure of the carbonyl component (R2 and R3).4,5 In
contrast to peptides, the hydrolysis of imidazolidin-4-ones
1 is not subjected to enzyme catalysis and thus imidazoli-
din-4-ones have been suggested as potentially useful pro-
drugs to protect the N-terminal amino acid residue of
peptides against aminopeptidase-catalyzed hydrolysis.6–8
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doi:10.1016/j.tet.2006.08.026Peptide imidazolidin-4-one derivatives, 1, are readily hydro-
lyzed to the parent peptide in pH 7.4 buffer at 37 C, usually
with half lives ranging from 1 to 30 h (Scheme 1).5–8 When
compared with the parent peptides several imidazolidin-4-
one prodrugs of Met-enkephalin and Leu-enkephalin, e.g.,
2, display improved stability in human plasma, rabbit liver
homogenate, and toward aminopeptidase.7 This prodrug
strategy has been extended to improve the bioavailability
of ampicillin, a b-lactam antibiotic that also contains a
a-aminoamide backbone; 2,4 the corresponding imidazolidin-
4-one, hetacillin (3), is rapidly hydrolyzed to ampicillin in
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9884 P. Chambel et al. / Tetrahedron 62 (2006) 9883–9891aqueous solutions 4 and in vivo.9 More recently, the imidazo-
lidin-4-one approach has been proposed to develop oil-in-
jectable depots for the a-aminoanilide anesthetic agent
prilocaine.10
We have recently synthesized the imidazolidin-4-ones 4 as
potential pro-prodrugs of the antimalarial primaquine, 5
(PQ).11,12 Compounds 4 were designed with the aim of re-
ducing the metabolic inactivation pathway of primaquine
that involves oxidative deamination at the primary amino
group,13–16 as well as to reduce the blood toxicity induced
by primaquine, particularly its ability to induce oxidation
of oxyhemoglobin to methemoglobin.17 The proposed
activation pathway of imidazolin-4-ones 4 implies the spon-
taneous hydrolysis to the corresponding amino acid deriva-
tives 6, which in turn can be enzymatically hydrolyzed to
the parent drug by parasitic aminopeptidases. In order to cir-
cumvent hydrolysis by the GI tract peptidases, the imidazo-
lidin-4-one pro-prodrug should hydrolyze at a rate that
allows quantitative formation of 6 after oral absorption.
Quite surprisingly, our initial studies showed that prima-
quine derived imidazolidin-4-ones 4 are reasonably stable
compounds, hydrolyzing to the corresponding amino acid
derivatives, 6, in pH 7.4 buffer at 37 C with half lives rang-
ing from 9 to 30 days,11,12 i.e., 50–100 times slower than
most of the imidazolidin-4-one counterparts derived from
di- and higher peptides. We were surprised by these large
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Odifferences in reactivity, as previous authors had suggested
that substituents at the N-3 nitrogen atom in dipeptide and
tripeptide imidazolidin-4-ones exert a small effect on hydro-
lysis rates.7 Obviously, understanding the reason for such
large differences in reactivity is fundamental to being able
to extend the imidazolidin-4-one prodrug approach to a-
aminoamides other than peptides. In this context, we now
present a kinetic study of hydrolysis of imidazolidin-4-
ones 4 undertaken to elucidate the structural factors that
affect their reactivity and to assess the usefulness of this pro-
drug type to other a-aminoamide drug moieties.
2. Results and discussion
2.1. Kinetics and products of hydrolysis
As revealed by HPLC analysis, all compounds 4 hydrolyze
quantitatively at 60 C to the corresponding amino acid de-
rivative 6 with first-order kinetics up to 4 half lives, over the
pH range 0.5–12. For the imidazolidin-4-one 4b it was also
possible to observe the hydrolysis of the corresponding ami-
no acid derivative 6 to primaquine at pH>10. An example of
product analysis is presented in Figure 1A for the hydrolysis
of compound 4b in pH 13.7, where the solid lines represent
the best computer fit to the experimental data of the consec-
utive first-order reactions model (i.e., 4/6/5) represented
by Eqs. 1–3.18
½4 ¼ ½40 ek1t ð1Þ
½6 ¼ ½40k1
k2  k1

ek1t  ek2t ð2Þ
½5 ¼ ½40
k2  k1

k2

1 ek1t k1

1 ek2t ð3Þ
Here [4]0 is the concentration of the imidazolidin-4-one at
time zero, and k1 and k2 are the pseudo-first-order rate con-
stants for the hydrolysis of the starting material 4 and amino
acid derivative 6, respectively (data not shown). For 6b (pri-
maquine-Phe), values of k2 so-obtained can be plotted versus
[OH] to obtain a value of kOH ¼ 3:6 102 M1 h1;
this compares favorably with the value of kOH ¼ 2:2
102 M1 h1 determined independently for the hydrolysis
of 6b in the same pH range (pH 11–13.7).
At pH values between 2 and 11 no formation of primaquine
was observed over the time-scale for the complete hydroly-
sis of 4b. However, formation of primaquinewas observed in
the hydrolysis of 4b at pH<2. The species profile for the hy-
drolysis at low pH values also fits the model for two consec-
utive first-order reactions (Fig. 1B). From the derived plot of
k2 versus [H
+], a value for kHþ of 1.5101 M1 h1 was
determined for the acid-catalyzed hydrolysis of 6b to prima-
quine, which compares favorably with the value of 2.0101
M1 h1 determined independently for the hydrolysis of 6b
over the same pH range (pH 0.3–2.0). The higher efficiency
of the acid-catalyzed hydrolysis of 6b when compared with
the alkaline hydrolysis can be ascribed to the stronger
9885P. Chambel et al. / Tetrahedron 62 (2006) 9883–9891electron-withdrawing ability of the protonated amino group
(pKa ca. 8.0)
19 over the corresponding neutral form
(s*NH3
+¼3.76; s*NH2¼0.62)20 that increases the reactivity
of the amide-carbonyl carbon atom toward nucleophiles.
The rates of hydrolyses of imidazolidin-4-ones 4 at a fixed
pH value were found to be independent of buffer concentra-
tion over a 10-fold buffer concentration range, indicating the
absence of general acid or base catalysis (Table 1). The in-
fluence of pH on the rate of hydrolysis of compounds 4 is
shown in Figure 2, where the logarithm of the observed
pseudo-first-order rate constant, k1, is plotted against pH.
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Figure 1. Time profile for the hydrolysis at 60 C of 4b (-) into PhePQ
(C) and PQ (B) in (A) 0.1 M NaOH and (B) 0.5 M HCl solutions.
Table 1. First-order rate constants for the hydrolysis of 4b in acetate and
phosphate buffers at 60 C, with ionic strength maintained at 0.5 mol dm3
by addition of NaClO4
Buffer [Buffer]/mol dm3 pH 102kobs/h
1
CH3CO2H 0.005 3.99 2.01
0.01 3.99 1.53
0.05 3.98 1.66
H2PO4
 0.002 6.01 1.75
0.005 6.05 1.65
0.01 5.95 1.72All pH–rate profiles have a sigmoid shape, with two pH-in-
dependent regions. Such sigmoid pH–rate profiles have been
reported for other imidazolidin-4-ones4,5 as well as for
their acyclic counterparts, N-Mannich bases,21 and can be
accounted for by assuming that both the protonated, SH+,
and the unionized, S, forms of the substrate undergo sponta-
neous hydrolysis (Scheme 2). The best computer fit (solid
line) to the experimental data for 4 in Figure 2 was achieved
using Eq. 4:
k1 ¼ kneut Ka
Ka þ

Hþ
þ kprot

Hþ

Ka þ

Hþ
 ð4Þ
where kneut and kprot are the apparent first-order rate con-
stants for the decomposition of neutral and protonated forms
of 4, Ka is the acid dissociation constant of the protonated 4,
and [H+]/(Ka+[H
+]) and Ka/(Ka+[H
+]) represent, respec-
tively, the fractions of the protonated and neutral forms of
4 present in solution. The kneut and kprot values derived either
from the pH–rate profiles or determined at pH 11 (for kneut)
and pH 0.3 (for kprot) are presented in Table 2. Also included
in Table 2 are the pKa values for compounds 4, derived from
the pH–rate profiles. The good agreement between the
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Figure 2. The pH–rate profiles for the hydrolysis of the imidazolidin-4-ones
4b (-), 4c (B), 4d (C), and 4e (,) in aqueous solutions at 60 C; the
insert is a plot of k1 versus pH for 4e.
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constants suggests that the degradation pathway presented
in Scheme 2 and Eq. 4 adequately describes the degradation
kinetics of compounds 4. The kinetically determined pKa
values are ca. 4 units lower than those of amino acid amides
(pKa ca. 7.5–8.0). A similar observation has been reported
for imidazolidin-4-ones derived from peptides6 and other
compounds containing an a-aminoamide moiety (e.g., prilo-
caine).10
2.2. Reactivity and mechanism of hydrolysis
A possible explanation for the unexpected chemical stability
of compounds 4 at physiological pH, when compared with
their peptide counterparts, may be found in their mechanism
of hydrolysis. According to Bundgaard and Rasmussen, imi-
dazolidin-4-ones hydrolyze at physiological pH, where the
kneut pathway is dominant, via an SN1-type mechanism
that involves C2–N3 bond cleavage and departure of an
amide anion leaving group (Scheme 3).6 Thus, the observed
differences in chemical stability may be ascribed to differ-
ences in the amide anion nucleofugacity. Indeed, amides re-
sulting from the rate-limiting ring opening of 4 are much
poorer leaving groups than those from dipeptide imidazoli-
din-4-ones, as suggested by the estimated difference of 3.3
pKa units between the two amide types.
22 Thus, how can
an apparently small difference in pKas dramatically affect
the reactivity? Let us assume that the pH-independent hydro-
lysis of imidazolidin-4-ones has the same susceptibility to
the leaving group effect as the acyclicN-Mannich base coun-
terparts, which hydrolyze via the same unimolecular mech-
anism.21 Since the Br€onsted blg value for this reaction is ca.
Table 2. First-order rate constants for the hydrolysis of the neutral, kneut, and
protonated, kprot, forms of the imidazolidin-4-ones 4, determined at 60
C,
with ionic strength maintained at 0.5 mol dm3 with addition of NaClO4,
also included are the pKa values determined from the pH–rate profile
Compound 102kneut/h
1 102kprot/h
1 pKa
4a 1.80 nd nd
4b 1.90 3.05 3.95
4c 1.32 1.09 3.70
4d 35.2 14.7 3.61
4e 5.02 5.61 3.98
4f 4.61 nd nd
4g 18.0; 0.160;a 1.08;b 2.55c nd nd
4h 3.62 nd nd
4i 2.46 8.34 nd
4j 1.69 nd nd
4k 265 1.27 nd
Not determined, nd.
a Reaction temperature: 37 C.
b Reaction temperature: 45 C.
c Reaction temperature: 50 C.1 (at 37 C), and assuming that the equation log k¼
pKa+C holds for compounds 4, then logðk1=k2Þ ¼
pK2a  pK1a and it would be expected that compounds 4 hy-
drolyze ca. 103 times slower than their counterparts derived
from dipeptides. The smaller differences reported previously
at 37 C might be attributed to the fact that the amino acid
chain affects both the amide anion leaving group ability as
well as the ability of the imidazolidin-4-one N-1 amino
nitrogen atom to expel the amide. Further support for the
unimolecular mechanism of hydrolysis of neutral imidazoli-
din-4-ones comes from the temperature dependence of kneut
for 4g (Table 2), which yielded an entropy of activation,DS#,
value of 25 J K1 mol1. Positive DS# values are consistent
with unimolecular mechanisms.23
Despite the limited data for the pH-independent hydrolysis
of the protonated form of imidazolidin-4-ones 4, it is inter-
esting to observe that kprot values range from 1.3102 to
1.5101 h1 at 60 C (Table 2). In contrast, imidazoli-
din-4-ones derived from peptides present kprot values rang-
ing from 8.4103 to 6.6102 h1 at 37 C.4–8,10 Thus,
the protonated form of primaquine derivatives 4 is also sig-
nificantly less reactive than the corresponding ionized form
of imidazolidin-4-ones derived from peptides. These results
are not consistent with a mechanism of decomposition in-
volving the rate-determining C2–N1 bond cleavage of the
imidazolidin-4-onewith departure of protonated amine leav-
ing group, i.e., 7. If this were the case, then dipeptide imida-
zolidin-4-ones would be predicted to be less reactive than 4
at low pH as a result of electron-withdrawing effect of the C-
terminal carboxyl group (7, R¼CO2H) on N-1 nitrogen atom
nucleophilicity. An alternative mechanismmight involve the
less favorable protonation of the carbonyl oxygen atom (the
pKa for the O-protonated amides is ca. 1)24, followed by
the C2–N3 bond scission, e.g., 8, as suggested for the hydro-
lysis of acyclic N-Mannich bases in the acidic region of
pH.25
H
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2.3. Structure and energetics
Theoretical calculations involving two models have been
used to simulate the imidazolidin-4-one ring of 4, both re-
ducing the parent primaquine (5) building block to a single
methyl group, c.f. R4 in Scheme 3; the first and smaller
model has substituents R1¼R2¼R3¼H and R4¼CH3, theN
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Figure 3. Optimized structures for the neutral (A), N-protonated (B), and O-protonated (C) species of the M1 model.second resembles the imidazolidin-4-one ring of compound
4b, i.e., with R1¼CH2Ph and R2¼R3¼R4¼CH3. These two
models are termed as M1 and M2 from now on. Selected
geometrical data for the neutral, N-protonated, and O-pro-
tonated M1 compounds are shown in Figure 3, while for
M2 compounds these parameters are given as Supplemen-
tary data.
The calculations performed on these models support the
hypothesis of alternative protonation sites, since the B3LYP/
6-31G* computed enthalpic difference between the most
stable N-protonated species and the O-protonated species
is only 7.0 and 31.0 kJ mol1 for M1 and M2 models, re-
spectively. These values are equal to the differences between
the gas-phase acidities of theN-protonated andO-protonated
compounds.
Much more interesting information is retrieved from AM1
and DFT calculations on the reaction of ring opening for
the neutral, N-protonated, and O-protonated M1 and M2species. The energetic barriers for the opening of the imida-
zolidin-4-one ring of the neutral M1 species are depicted in
Figure 4. These barriers are consistent with a unimolecular
pathway for the hydrolysis of neutral 4, since the energetic
barrier for the alternative pathway involving participation
of a water molecule is significantly higher than that com-
puted without water. For the neutral M2 species, AM1 and
B3LYP energetic barriers are 172 and 186 kJ mol1, respec-
tively. The transition state structures have only one imagi-
nary AM1 or B3LYP calculated frequency with values 196
or 81 cm1, respectively. Again, as found for the neutral
M1 species, the AM1 energetic barrier is in good agreement
with that computed at the B3LYP/6-31G* level of theory.
The computed energetic barriers are much lower for the N-
protonated and O-protonated species as reported in Table 3.
For theM1model, the B3LYP/6-31G* computed barrier for
the ring opening in the N-protonated species is 74 kJ mol1,
while for the O-protonated species, a smaller barrier is
found, c.f., 64 kJ mol1. The order of the energetic barriers0
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Figure 4. Energy profile for the imidazolidinone ring opening reaction, with and without a water molecule, computed at the AM1 and B3LYP/6-31G* levels of
theory. The zero of energy corresponds to the reactant with or without a water molecule. Full line: AM1 in the absence of water and numbers in italic; dashed
line: B3LYP in the absence of water with numbers underlined; dotted line: B3LYP in the presence of one water molecule with numbers in normal text.
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the N-protonated species and 80 kJ mol1 for the O-proton-
ated species. Nevertheless, the small difference between the
energetic barriers of these species gives further support to
the possibility of a reaction mechanism involving an O-pro-
tonated species, as suggested previously.25 Finally, for
the M2 model AM1 calculations reveal the energetic
barriers to be 32 and 42 kJ mol1 for the N-protonated and
O-protonated compounds, respectively, suggesting that the
reaction is faster in the case of the model resembling com-
pound 4b.
At first glance, the differences between the computed energy
barriers for either the neutral or the protonated forms of sub-
strate indicate that protonated imidazolidinones would be
markedly less stable than their neutral forms. However,
ring opening of the neutral form leads to charge separation
in the gas-phase, i.e., to the formation of a highly disfavored
zwitterionic species in the gaseous state. Solvation effects in
aqueous media probably allow this species to be much more
stabilized, thus energetically closer to the cationic species
formed from the protonated substrate, which explains our
experimental observation of kneut and kprot of similar magni-
tude for imidazolidin-4-ones 4b,c,e.
2.4. Structural effects on chemical reactivity
Inspection of the kinetic data presented in Table 2 reveals
that the pH-independent pathway rate constant predominant
at physiological pH, kneut, decreases with the increasing size
of the amino acid substituent R1. This effect is more evident
for the cyclopentanone, 4d–f, and cyclohexanone, 4g–j,
derived series than for the corresponding acetone derived se-
ries, 4a–c. Indeed a good correlation was obtained between
log kneut for the cyclohexanone, 4g–j, series and Charton’s
steric parameter, n, for the amino acid substituent R1
(Fig. 5). A good correlation, with a slope of 1.2, was
also determined for the three cyclopentanone derivatives
4d–f. The negative sign of the steric term in the correlations
indicates that steric crowding of the amino acid substituent
retards the hydrolysis reaction of the neutral substrate. Al-
though this may seem unusual for an SN1-type reaction,
for which release of steric strain on going from reactant to
the transition state usually leads to rate enhancement, it
might be ascribed to unfavorable steric interactions between
the amino acid substituent and the R2 and R3 substituents in
the iminium ion 9 (Scheme 3). Interestingly, when we ana-
lyzed the published data on dipeptide imidazolidin-4-ones
Table 3. Computed free energy differences (kJ mol1) of TS and final
product with respect to the initial (free energy¼0) neutral, N-protonated,
and O-protonatedM1 andM2 imidazolidinone models, imaginary frequen-
cies (cm1) of the TS are also given
Compound AM1 B3LYP
TS Product Frequency TS Product Frequency
M1 neutral+H2O — — — 304 4 629
M1 neutral 220 209 247 219 16 164
M1 N-protonated 58 7 469 74 64 186
M1 O-protonated 80 2 465 64 33 117
M2 neutral 172 151 196 186 4 81
M2 N-protonated 32 30 387 79 60 85
M2 O-protonated 42 77 419 — — —(1; R2¼R3¼Me; R1¼H, Me, CH2Ph; R4¼phenylalanine;
data determined at 37 C6), we found a reasonable correla-
tion between log kneut and Charton’s steric parameter, n,
for the amino acid substituent:
log kneut ¼0:74n 2:27

r2 ¼ 0:958; n¼ 3 ð5Þ
The rate data presented in Table 2 show that the nature of the
substituents at C-2 of the imidazolidin-4-one moiety, and
thus the ketone starting material, affects the reactivity of
the neutral form of the imidazolidin-4-ones 4. Interestingly,
the order of reactivity for the glycine derivatives, according
to the ketone starting material, is: cycloheptanone>
cyclopentanone>cyclohexanone>acetone, the cyclohepta-
none compound 4k being ca. 150 times more reactive
than its acetone counterpart, 4a. A similar trend has
been reported for imidazolidin-4-ones derived from enkeph-
alins, where the order of reactivity is cyclopentanone>
cyclohexanone>acetone.7
The higher reactivity of the seven- and five-membered ring
derivatives, 4d,k, when compared with the six-membered
ring derivative 4g, finds parallel in the solvolysis of cyclo-
alkyl halides and sulfonates and can be explained by
Brown’s I-strain (internal strain) effect.26–28 Accordingly,
seven- and five-membered rings are strained, and reactions
involving a change in coordination number of one of the car-
bon atoms from four to three, as in SN1-type reactions, will
lead to a decrease in internal strain. In contrast, six-mem-
bered halides and sulfonates are perfectly staggered and
strain-free, and changes in coordination number from four
to three will lead to an increase in internal strain and to a
decrease in reactivity. Thus, the smaller kneut value for the
cyclohexanone derivative 4g, when compared with the five-
and seven-membered ring derivatives 4d,k, is also consistent
with an SN1-type unimolecular mechanism. The reactivity of
the acetone imidazolidin-4-one 4a can be ascribed to the
lower stability of the corresponding ion 9 when compared
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Figure 5. Plot of log kneut versus Charton’s steric parameter, n, for the R
1
substituent in imidazolidin-4-ones 4g–j; the correlation equation for the
line is: log kneut ¼ 1:30n 0:75 ðr2 ¼ 0:993; n ¼ 4Þ.
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that the isopropyl cation is ca. 30–40 kcal mol1 less stable
than methylcyclopentyl or methylcyclohexyl cation.29
Most of the kneut and kprot values for imidazolidin-4-ones 4
are of the same order of magnitude, with rate differences
less than two-fold for 4b,c,e (Table 2). In contrast, the
protonated form of the cycloheptanone derivative 4k is ca.
200 times less reactive than the corresponding neutral
form. Interestingly, the order of reactivity for the phenylala-
nine derivatives, according to the ketone starting material, is:
cyclohexanone>cyclopentanone>acetone, the cyclohexa-
none compound 4i being ca. 3 times more reactive than its
acetone counterpart, 4b. Although a similar order of reactiv-
ity has been reported for imidazolidin-4-ones derived from
enkephalins,7 we cannot find an obvious explanation for
these observations.
3. Implications in prodrug design
Imidazolidin-4-ones have been considered as useful chemi-
cally activated prodrugs for di- and larger peptides because
of their reasonably rapid hydrolysis to the parent peptides
in physiological conditions, i.e., pH 7.4 at 37 C. Since the
mechanism of hydrolysis of imidazolidin-4-ones is likely
to involve the SN1-type unimolecular cleavage of the C2–
N3 bond with departure of an amide-leaving group, the
rate of hydrolysis of this class of prodrugs will be highly de-
pendent on the pKa of the amide, which, in turn, is largely
dependent on the nature of the amide nitrogen atom sub-
stituent (Scheme 3, 11, R4). The results herein presented
indicate that simple N-alkyl a-aminoamide drugs (11,
R4¼alkyl), in contrast to peptides, will lead to stable imida-
zolidin-4-ones, which may be useful as slow drug release
prodrugs. Increasing the size of the substituents at the a-car-
bon of the a-aminoamide parent drug will also decrease the
rate of hydrolysis of the corresponding imidazolidin-4-one
prodrug. In contrast, substitution at C-2 of the imidazoli-
din-4-one moiety will increase the rate of hydrolysis, partic-
ularly when imidazolidin-4-one prodrugs derived from
cyclopentanone and cycloheptanone. In summary, the scope
of imidazolidin-4-ones as prodrugs is now expanded and can
encompass a-aminoamide drugs other than peptides.
4. Experimental
4.1. General details
Na-Protected amino acids were purchased from Bachem
(Switzerland). Solvents were of p.a. quality and bought
from Merck (Germany). Both thin layer chromatography
(TLC) aluminum foil plates covered with silica 60 F254
(0.25 mm) and silica gel 60 (70–230 mesh ASTM) for pre-
parative column chromatography were also purchased
from Merck. When required, solvents were previously dried
with pre-activated molecular sieves (4 A˚) (Merck). Other
chemicals were obtained from Sigma–Aldrich.
NMR spectra were recorded on a Br€uker AMX-300
spectrometer in deuterated chloroform (CDCl3) containing
tetramethylsilane (TMS) as an internal reference. Massspectrometry (MS) was performed by the matrix-assisted la-
ser desorption ionization-time-of-flight (MALDI-TOF)
technique on an Applied Biosystems Voyager STR-DE spec-
trometer, using either anthracene or 2,5-dihydroxybenzoic
acid (DHB) as adjuvant matrices.
4.2. Synthesis of imidazolidin-4-ones 4
The aminoacyl derivatives of primaquine 6 (2 mmol) were
mixed with an excess (4 mmol) of the appropriate ketone
(acetone, cyclopentanone, cyclohexanone, or cyclohepta-
none) and triethylamine (TEA, 2 mmol) in dry methanol
(10 ml) and the mixture was refluxed for 3 days in the pres-
ence of 4 A˚ molecular sieves (1 g). The reaction was moni-
tored by TLC and ketone was re-added (2 mmol) once per
day. The molecular sieves were removed by decantation
and the solution was evaporated to dryness. The oily residue
was submitted to column chromatography on silica gel,
eluted with DCM/THF (varying solvent proportions) or,
for compound 4a, DCM/ethanol 15:1 (v/v). Fractions
containing the chromatographically homogeneous product
were pooled and evaporated to dryness, yielding 4a–k as
yellow-orange oils (44 to 81%) that were analyzed
by high-resolution MS and NMR. Spectroscopic and analyt-
ical data for compounds 4a–k have been presented in
Ref. 11.
4.3. Kinetics of hydrolysis
The kinetics of hydrolysis of imidazolidin-4-ones 4 were
studied by HPLC using a Waters assembly equipped with a
model 600 controlled pump and a model 991 photodiode-
array detector set at 265 nm. The separation was performed
on a Purospher, 2504.0-mm i.d. 5 mm analytical column.
The mobile phase consisted of a mixture of acetonitrile and
sodium acetate buffer (pH 4.75, 0.05 M) containing 103 M
triethylamine. Two gradients were developed: one for the
imidazolidin-4-one derivatives of phenylalanine and the
other for the derivatives of valine. A linear gradient method
using 50–90% (v/v) acetonitrile over 20 min was used for
compounds 4b,e,i, while a linear gradient using 60–90%
(v/v) acetonitrile over 20 min was used for compounds
4c,f,j. For the remaining compounds, an isocratic method
was developed using a mixture of acetonitrile and pH 4.75
acetate buffer (50:50 to 60:40%) containing 103 M triethyl-
amine.
The kinetics of hydrolysis of imidazolin-4-ones 4were stud-
ied at 600.1 C, in aqueous buffers with ionic strength kept
at 0.5 M by the addition of NaClO4. The buffers used were
acetate (pH 4.0–5.0), phosphate (pH 6.0–7.5), and borate
(pH 8.0–11.5). For acetate and phosphate buffers the effect
of buffer concentration was studied in the range 0.01–
0.20 M. Sodium hydroxide and hydrochloric acid pseudo-
buffers were used at pH higher than 12.0 and lower
than 2.5, respectively. Typically, reactions were initiated
by injecting a 10 ml aliquot of a 102 M stock solution of
substrate in acetonitrile to 10 ml of the appropriate thermo-
stated buffer solution. At regular intervals, samples of
the reaction mixture were analyzed by HPLC. All reactions
followed first-order kinetics over four half lives.
Rate constants derived using this method were reproducible
to 6%.
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The semiempirical Austin Model 1, AM1,30 and the density-
functional theory, DFT, based B3LYP 31–33 methods have
been used as included in the Gaussian 98 computer code.34
These two methods have been parameterized in order to re-
produce experimentally measured molecular properties. The
simplest AM1 method is based on the neglect of differential
diatomic overlap formalism in which various Fockmatrix el-
ements are set to zero or use parameters optimized to repro-
duce various properties such as molecular geometries and
standard gas-phase enthalpies of formation. This approach
is an evolution of the older Modified Neglect of Differential
Overlap, MNDO, method where some deficiencies, such as
poor reproduction of hydrogen bonds and too high reaction
activation energies, have been corrected. In the hybrid
B3LYPmethod, three parameters of the exchange functional
were optimized empirically in order to reproduce experi-
mental thermochemical data. The optimum mixing was
found forw20% Fock exchange in the exchange functional.
In the B3LYP calculations reported here, the atomic elec-
tronic density has been described by the standard 6-31G(d)
basis set.
Transition states were localized using the STQN method,
QST3 and IRC calculations were performed in order to be
certain that these TS structures yield the closed-ring (reac-
tants) and open-ring (products) structures. Further, reactants
and products did not present any imaginary frequency while
only a single imaginary frequency was calculated for transi-
tion states. All figures with molecular structures have been
obtained with the XCrysDen35 and Molden36 programs.
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